Browsing: MHRA
Johnson & Johnson announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib)…
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the use of cystic fibrosis medicines…